Article
RhoC: a fascinating journey from a cytoskeletal organizer to a Cancer stem cell therapeutic target
24 Jul 2019
Abstract excerpt
Tumor heterogeneity results in differential response to therapy due to the existence of plastic tumor cells, called cancer stem cells (CSCs), which exhibit the property of resistance to therapy, invasion and metastasis. These cells have a distinct, signaling network active at every stage of progression. It is difficult to envisage that the CSCs will have a unique set of signaling pathways regulating every stage...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
